MENU
OCS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Oculis Holding AG (OCS) Ownership - Who owns Oculis Holding AG?
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care... Show more
Profile
Industry
N/A
Address
Bahnhofstrasse 7
Phone
+41 417119325
Employees
N/A
Web
https://www.oculis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
858.72M
P/E Ratio
63.08
Total Cash
98.66M
Projected Growth
N/A
Total Debt
1.18M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
OCS
Capitalization
859M
P/E Ratio
63.08
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
98.7M
Total Cash/Share
2.06
Total Debt
1.18M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
73.4M
P/B Ratio
9.47
Cash Flow
N/A
Earnings
-2.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
446K
Current Ratio
2.37
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-84.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-73.09
Shares Held By Institutions
66.1M
Shares Outstanding - Current
48M
Total Liabilities
47M
Total Volume MTD
N/A
Value
-1
Gain YTD
5.235
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Bahnhofstrasse 7
Phone
+41 417119325
Employees
N/A
Web
https://www.oculis.com